Erratum: Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance (Proceedings of the National Academy of Sciences of the United States of America (2016) 113 (4723-4728) DOI: 10.1073/pnas.1519128113);Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 17, 2016, Pages 4723-4728

  Rentoft, Matilda ^a   Lindell, Kristoffer ^a   Tran, Phong ^a   Chabes, Anna Lena ^a   Buckland, Robert J ^a   Watt, Danielle L ^a   Marjavaara, Lisette ^a   Nilsson, Anna Karin ^a   Melin, Beatrice ^a   Trygg, Johan ^a   Johansson, Erik ^a   Chabes, Andrei ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Colon cancer; DNA replication fidelity; DNTP pools

Indexed keywords

DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; HISTIDINE ASPARTATE DOMAIN CONTAINING PROTEIN 1; UNCLASSIFIED DRUG; DEOXYRIBONUCLEOTIDE; DNA; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; SAMHD1 PROTEIN, HUMAN; SAMHD1 PROTEIN, MOUSE;

ALLELE; ANIMAL CELL; ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; EMBRYO; MISMATCH REPAIR; MOUSE; MUTATION; MUTATION RATE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; SOMATIC MUTATION; ANIMAL; C57BL MOUSE; COLON TUMOR; DNA REPLICATION; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HUMAN; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DEOXYRIBONUCLEOTIDES; DNA REPLICATION; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MICE; MICE, INBRED C57BL; MONOMERIC GTP-BINDING PROTEINS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84964773876     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1902081116     Document Type: Erratum

References (69)

1. Schmitt MW, et al. (2015) Sequencing small genomic targets with high efficiency and extreme accuracy. Nat Methods 12(5):423-425.
2. Wang Y, et al. (2014) Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512(7513):155-160.
3. Fox EJ, Loeb LA (2014) Cancer: One cell at a time. Nature 512(7513):143-144.
4. Loeb LA, Springgate CF, Battula N (1974) Errors in DNA replication as a basis of malignant changes. Cancer Res 34(9):2311-2321.
5. Schmitt MW, Prindle MJ, Loeb LA (2012) Implications of genetic heterogeneity in cancer. Ann N Y Acad Sci 1267:110-116.
6. Kunkel TA (2009) Evolving views of DNA replication (in)fidelity. Cold Spring Harb Symp Quant Biol 74:91-101.
7. Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 7(4):197-208.
8. Buckland RJ, et al. (2014) Increased and imbalanced dNTP pools symmetrically promote both leading and lagging strand replication infidelity. PLoS Genet 10(12):e1004846.
9. Watt DL, Buckland RJ, Lujan SA, Kunkel TA, Chabes A (2016) Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools. Nucleic Acids Res 44(4):1669-1680.
10. Kumar D, Viberg J, Nilsson AK, Chabes A (2010) Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint. Nucleic Acids Res 38(12):3975-3983.
11. Chabes A, et al. (2003) Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase. Cell 112(3):391-401.
12. Sabouri N, Viberg J, Goyal DK, Johansson E, Chabes A (2008) Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage. Nucleic Acids Res 36(17):5660-5667.
13. Stone JE, et al. (2011) Lesion bypass by S. cerevisiae Pol alone. DNA Repair (Amst) 10(8):826-834.
14. Gon S, Napolitano R, Rocha W, Coulon S, Fuchs RP (2011) Increase in dNTP pool size during the DNA damage response plays a key role in spontaneous and inducedmutagenesis in Escherichia coli. Proc Natl Acad Sci USA 108(48):19311-19316.
15. Kunz BA, et al. (1994) International Commission for Protection Against Environmental Mutagens and Carcinogens. Deoxyribonucleoside triphosphate levels: A critical factor in the maintenance of genetic stability. Mutat Res 318(1):1-64.
16. Ahluwalia D, Schaaper RM (2013) Hypermutability and error catastrophe due to defects in ribonucleotide reductase. Proc Natl Acad Sci USA 110(46):18596-18601.
17. Mertz TM, Sharma S, Chabes A, Shcherbakova PV (2015) Colon cancer-associated mutator DNA polymerase ? variant causes expansion of dNTP pools increasing its own infidelity. Proc Natl Acad Sci USA 112(19):E2467-E2476.
18. Williams LN, et al. (2015) dNTP pool levels modulate mutator phenotypes of errorprone DNA polymerase e variants. Proc Natl Acad Sci USA 112(19):E2457-E2466.
19. Sohl CD, Ray S, Sweasy JB (2015) Pools and Pols: Mechanism of a mutator phenotype. Proc Natl Acad Sci USA 112(19):5864-5865.
20. Mathews CK (2015) Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer 15(9):528-539.
21. Goldstone DC, et al. (2011) HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480(7377):379-382.
22. Beloglazova N, et al. (2013) Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem288(12):8101-8110.
23. Rice GI, et al. (2009) Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41(7):829-832.
24. Laguette N, et al. (2011) SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474(7353):654-657.
25. Hrecka K, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474(7353):658-661.
26. Laguette N, Benkirane M (2012) How SAMHD1 changes our view of viral restriction. Trends Immunol 33(1):26-33.
27. Ryoo J, et al. (2014) The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 20(8):936-941.
28. Seamon KJ, Sun Z, Shlyakhtenko LS, Lyubchenko YL, Stivers JT (2015) SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity. Nucleic Acids Res 43(13):6486-6499.
29. Franzolin E, et al. (2013) The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells. Proc Natl Acad Sci USA 110(35):14272-14277.
30. Clifford R, et al. (2014) SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 123(7):1021-1031.
31. Schuh A, et al. (2012) Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120(20): 4191-4196.
32. Landau DA, et al. (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152(4):714-726.
33. Wang JL, Lu FZ, Shen XY, Wu Y, Zhao LT (2014) SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun 455(3-4):229-233.
34. de Silva S, et al. (2014) Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sézary syndrome patients. J Invest Dermatol 134(2):562-565.
35. Kohnken R, Kodigepalli KM, Wu L (2015) Regulation of deoxynucleotide metabolism in cancer: Novel mechanisms and therapeutic implications. Mol Cancer 14:176.
36. Forbes SA, et al. (2011) COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39(Database issue):D945-D950.
37. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185(4154):862-864.
38. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073-1081.
39. Adzhubei IA, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248-249.
40. Kircher M, et al. (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310-315.
41. Ji X, Tang C, Zhao Q, Wang W, Xiong Y (2014) Structural basis of cellular dNTP regulation by SAMHD1. Proc Natl Acad Sci USA 111(41):E4305-E4314.
42. Zhu C, et al. (2013) Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. Nat Commun 4:2722.
43. Donehower LA, et al. (2013) MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. J Pathol 229(1): 99-110.
44. Dees ND, et al. (2012) MuSiC: Identifying mutational significance in cancer genomes. Genome Res 22(8):1589-1598.
45. Esplin ED, Snyder MP (2014) Genomic era diagnosis and management of hereditary and sporadic colon cancer. World J Clin Oncol 5(5):1036-1047.
46. Oikonomou E, Pintzas A (2006) Cancer genetics of sporadic colorectal cancer: BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies. Anticancer Res 26(2A):1077-1084.
47. Kunz BA (1988) Mutagenesis and deoxyribonucleotide pool imbalance. Mutat Res 200(1-2):133-147.
48. Meuth M (1989) The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res 181(2):305-316.
49. Papadopoulos N, et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263(5153):1625-1629.
50. Tili E, et al. (2011) Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci USA 108(12):4908-4913.
51. Agbor AA, Göksenin AY, LeCompte KG, Hans SH, Pursell ZF (2013) Human Pol e-dependent replication errors and the influence of mismatch repair on their correction. DNA Repair (Amst) 12(11):954-963.
52. Glaab WE, Tindall KR (1997) Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18(1):1-8.
53. Bjursell G, Reichard P (1973) Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem 248(11):3904-3909.
54. Nick McElhinny SA, et al. (2010) Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci USA 107(11):4949-4954.
55. Reichard P (1988) Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 57:349-374.
56. Behrendt R, et al. (2013) Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Reports 4(4):689-696.
57. Rehwinkel J, et al. (2013) SAMHD1-dependent retroviral control and escape in mice. EMBO J 32(18):2454-2462.
58. Rayner E, et al. (2016) A panoply of errors: Polymerase proofreading domain mutations in cancer. Nat Rev Cancer 16(2):71-81.
59. Zhao X, Muller EG, Rothstein R (1998) A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools. Mol Cell 2(3):329-340.
60. Poli J, et al. (2012) dNTP pools determine fork progression and origin usage under replication stress. EMBO J 31(4):883-894.
61. Lopez-Contreras AJ, et al. (2015) Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. Genes Dev 29(7):690-695.
62. Bester AC, et al. (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145(3):435-446.
63. Håkansson P, Hofer A, Thelander L (2006) Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem 281(12): 7834-7841.
64. Niida H, et al. (2010) Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase. Genes Dev 24(4): 333-338.
65. Hu CM, et al. (2012) Tumor cells require thymidylate kinase to prevent dUTP incorporation during DNA repair. Cancer Cell 22(1):36-50.
66. Castro-Giner F, Ratcliffe P, Tomlinson I (2015) The mini-driver model of polygenic cancer evolution. Nat Rev Cancer 15(11):680-685.
67. Amie SM, et al. (2013) Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels. J Biol Chem 288(28):20683-20691.
68. Yan J, et al. (2013) Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection. J Biol Chem 288(15):10406-10417.
69. Jia S, Marjavaara L, Buckland R, Sharma S, Chabes A (2015) Determination of deoxyribonucleoside triphosphate concentrations in yeast cells by strong anionexchange high-performance liquid chromatography coupled with ultraviolet detection. Methods Mol Biol 1300:113-121.